Jacqueline L. Norrie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jacqueline L. Norrie has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Abbas Shirinifard
13 shared publicationsArdiana Moustaki
13 shared publicationsRosa Nguyen
13 shared publicationsShantel Brown
13 shared publications- Walter J. Akers
Washington University School of Medicine, Department of Radiology, 4525 Scott Avenue, St. Louis, Missouri 63110, United States
13 shared publications Michael A. Dyer
12 shared publications
Latest Publications
- Open Access
- 12 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104271
Protocol for retinal stress culture and single-cell analysis
- 12 December 2025
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104271
Open AccessProtocol for retinal stress culture and single-cell analysis
- Open Access
- 1 July 2024
- Published by The Company of Biologists in Development
- Vol. 151 (13)
Evolutionary conservation of VSX2 super-enhancer modules in retinal development
Super-enhancers (SEs) are expansive regions of genomic DNA that regulate the expression of genes involved in cell identity and cell fate. We recently identified developmental stage- and cell type-specific modules within the murine Vsx2 SE. Here, we show that the human VSX2 SE modules have similar developmental stage- and cell type-specific activity in reporter gene assays. By inserting the human sequence of one VSX2 SE module into a mouse with microphthalmia, eye size was rescued. To understand the function of these SE modules during human retinal development, we deleted individual modules in human embryonic stem cells and generated retinal organoids. Deleting one module results in small organoids, recapitulating the small-eyed phenotype of mice with microphthalmia, while deletion of the other module led to disruptions in bipolar neuron development. This prototypical SE serves as a model for understanding developmental stage- and cell type-specific effects of neurogenic transcription factors with complex expression patterns. Moreover, by elucidating the gene regulatory mechanisms, we can begin to examine how dysregulation of these mechanisms contributes to phenotypic diversity and disease.
- 1 July 2024
- Published by The Company of Biologists in Development
- Vol. 151 (13)
Open AccessEvolutionary conservation of VSX2 super-enhancer modules in retinal development
Super-enhancers (SEs) are expansive regions of genomic DNA that regulate the expression of genes involved in cell identity and cell fate. We recently identified developmental stage- and cell type-specific modules within the murine Vsx2 SE. Here, we show that the human VSX2 SE modules have similar developmental stage- and cell type-specific activity in reporter gene assays. By inserting the human sequence of one VSX2 SE module into a mouse with microphthalmia, eye size was rescued. To understand the function of these SE modules during human retinal development, we deleted individual modules in human embryonic stem cells and generated retinal organoids. Deleting one module results in small organoids, recapitulating the small-eyed phenotype of mice with microphthalmia, while deletion of the other module led to disruptions in bipolar neuron development. This prototypical SE serves as a model for understanding developmental stage- and cell type-specific effects of neurogenic transcription factors with complex expression patterns. Moreover, by elucidating the gene regulatory mechanisms, we can begin to examine how dysregulation of these mechanisms contributes to phenotypic diversity and disease.
- Open Access
Identification of Evolutionarily Conserved VSX2 Enhancers in Retinal Development
Super-enhancers (SEs) are expansive regions of genomic DNA that regulate the expression of genes involved in cell identity and cell fate. Recently, we found that distinct modules within a murine SE regulate gene expression of master regulatory transcription factor Vsx2 in a developmental stage- and cell-type specific manner. Vsx2 is expressed in retinal progenitor cells as well as differentiated bipolar neurons and Müller glia. Mutations in VSX2 in humans and mice lead to microphthalmia due to a defect in retinal progenitor cell proliferation. Deletion of a single module within the Vsx2 SE leads to microphthalmia. Deletion of a separate module within the SE leads to a complete loss of bipolar neurons, yet the remainder of the retina develops normally. Furthermore, the Vsx2 SE is evolutionarily conserved in vertebrates, suggesting that these modules are important for retinal development across species. In the present study, we examine the ability of these modules to drive retinal development between species. By inserting the human build of one Vsx2 SE module into a mouse with microphthalmia, eye size was rescued. To understand the implications of these SE modules in a model of human development, we generated human retinal organoids. Deleting one module results in small organoids, recapitulating the small-eyed phenotype of mice with microphthalmia, while deletion of the other module leads to a complete loss of ON cone bipolar neurons. This prototypical SE serves as a model for uncoupling developmental stage- and cell-type specific effects of neurogenic transcription factors with complex expression patterns. Moreover, by elucidating the gene regulatory mechanisms, we can begin to examine how dysregulation of these mechanisms contributes to phenotypic diversity and disease. Summary Statement: Herein, we describe how conserved modules within a single super-enhancer can regulate VSX2 gene expression across species in both mice and human retinal organoids.
Open AccessIdentification of Evolutionarily Conserved VSX2 Enhancers in Retinal Development
Super-enhancers (SEs) are expansive regions of genomic DNA that regulate the expression of genes involved in cell identity and cell fate. Recently, we found that distinct modules within a murine SE regulate gene expression of master regulatory transcription factor Vsx2 in a developmental stage- and cell-type specific manner. Vsx2 is expressed in retinal progenitor cells as well as differentiated bipolar neurons and Müller glia. Mutations in VSX2 in humans and mice lead to microphthalmia due to a defect in retinal progenitor cell proliferation. Deletion of a single module within the Vsx2 SE leads to microphthalmia. Deletion of a separate module within the SE leads to a complete loss of bipolar neurons, yet the remainder of the retina develops normally. Furthermore, the Vsx2 SE is evolutionarily conserved in vertebrates, suggesting that these modules are important for retinal development across species. In the present study, we examine the ability of these modules to drive retinal development between species. By inserting the human build of one Vsx2 SE module into a mouse with microphthalmia, eye size was rescued. To understand the implications of these SE modules in a model of human development, we generated human retinal organoids. Deleting one module results in small organoids, recapitulating the small-eyed phenotype of mice with microphthalmia, while deletion of the other module leads to a complete loss of ON cone bipolar neurons. This prototypical SE serves as a model for uncoupling developmental stage- and cell-type specific effects of neurogenic transcription factors with complex expression patterns. Moreover, by elucidating the gene regulatory mechanisms, we can begin to examine how dysregulation of these mechanisms contributes to phenotypic diversity and disease. Summary Statement: Herein, we describe how conserved modules within a single super-enhancer can regulate VSX2 gene expression across species in both mice and human retinal organoids.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 5 A, Differential gene expression of IL-15-treated NK cells compared to IL-2. B, Functional categories of differentially expressed genes.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 5 A, Differential gene expression of IL-15-treated NK cells compared to IL-2. B, Functional categories of differentially expressed genes.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S4 Weekly weight trends in mice treated with chemotherapy or chemoimmunotherapy.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S4 Weekly weight trends in mice treated with chemotherapy or chemoimmunotherapy.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S2. Cytotoxic activity of NK cells from CD1-Foxn1nu mice. A, The MHC class II-deficient mouse lymphoma cell line, YAC-1, was used to test NK cell cytotoxicity. B, IL-2 (dark gray) or IL-15-activated (light gray) NK cells isolated from the spleen of CD1-Foxn1nu mice were plated with YAC-1 cells at an E:T ratio of 5:1 and 2.5:1 for the duration of 4 hours. Specific tumor lysis was significantly higher with NK cells activated with IL-15 than with IL-2. C, Xenoreactivity of murine NK cells against K562 and SJNBL46_X (PDX) with (+AB) and without antibody compared to YAC-1. D, CD107a expression was increased in IL-2- and IL-15-preactivated NK cells compared to resting NK cells after co-culture with YAC-1. E, To quantitate IFN-γ expression, NK cells were stimulated with IL-12/IL-18 in culture (red). Unstimulated NK cells served as controls (gray). IL-15 preactivation was associated with higher IFN-γ expression than was IL-2 or no preactivation. F, Expression analysis of perforin and granzyme B. The expression of perforin was slightly higher in IL-15 than in IL-2-activated NK cells; however, granzyme B was similar.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S2. Cytotoxic activity of NK cells from CD1-Foxn1nu mice. A, The MHC class II-deficient mouse lymphoma cell line, YAC-1, was used to test NK cell cytotoxicity. B, IL-2 (dark gray) or IL-15-activated (light gray) NK cells isolated from the spleen of CD1-Foxn1nu mice were plated with YAC-1 cells at an E:T ratio of 5:1 and 2.5:1 for the duration of 4 hours. Specific tumor lysis was significantly higher with NK cells activated with IL-15 than with IL-2. C, Xenoreactivity of murine NK cells against K562 and SJNBL46_X (PDX) with (+AB) and without antibody compared to YAC-1. D, CD107a expression was increased in IL-2- and IL-15-preactivated NK cells compared to resting NK cells after co-culture with YAC-1. E, To quantitate IFN-γ expression, NK cells were stimulated with IL-12/IL-18 in culture (red). Unstimulated NK cells served as controls (gray). IL-15 preactivation was associated with higher IFN-γ expression than was IL-2 or no preactivation. F, Expression analysis of perforin and granzyme B. The expression of perforin was slightly higher in IL-15 than in IL-2-activated NK cells; however, granzyme B was similar.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 1. Expression of NK cell exhaustion markers in tumorsphere-infiltrating and non-infiltrating NK cells by flow cytometry.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 1. Expression of NK cell exhaustion markers in tumorsphere-infiltrating and non-infiltrating NK cells by flow cytometry.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 5 A, Differential gene expression of IL-15-treated NK cells compared to IL-2. B, Functional categories of differentially expressed genes.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure 5 A, Differential gene expression of IL-15-treated NK cells compared to IL-2. B, Functional categories of differentially expressed genes.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S2. Cytotoxic activity of NK cells from CD1-Foxn1nu mice. A, The MHC class II-deficient mouse lymphoma cell line, YAC-1, was used to test NK cell cytotoxicity. B, IL-2 (dark gray) or IL-15-activated (light gray) NK cells isolated from the spleen of CD1-Foxn1nu mice were plated with YAC-1 cells at an E:T ratio of 5:1 and 2.5:1 for the duration of 4 hours. Specific tumor lysis was significantly higher with NK cells activated with IL-15 than with IL-2. C, Xenoreactivity of murine NK cells against K562 and SJNBL46_X (PDX) with (+AB) and without antibody compared to YAC-1. D, CD107a expression was increased in IL-2- and IL-15-preactivated NK cells compared to resting NK cells after co-culture with YAC-1. E, To quantitate IFN-γ expression, NK cells were stimulated with IL-12/IL-18 in culture (red). Unstimulated NK cells served as controls (gray). IL-15 preactivation was associated with higher IFN-γ expression than was IL-2 or no preactivation. F, Expression analysis of perforin and granzyme B. The expression of perforin was slightly higher in IL-15 than in IL-2-activated NK cells; however, granzyme B was similar.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S2. Cytotoxic activity of NK cells from CD1-Foxn1nu mice. A, The MHC class II-deficient mouse lymphoma cell line, YAC-1, was used to test NK cell cytotoxicity. B, IL-2 (dark gray) or IL-15-activated (light gray) NK cells isolated from the spleen of CD1-Foxn1nu mice were plated with YAC-1 cells at an E:T ratio of 5:1 and 2.5:1 for the duration of 4 hours. Specific tumor lysis was significantly higher with NK cells activated with IL-15 than with IL-2. C, Xenoreactivity of murine NK cells against K562 and SJNBL46_X (PDX) with (+AB) and without antibody compared to YAC-1. D, CD107a expression was increased in IL-2- and IL-15-preactivated NK cells compared to resting NK cells after co-culture with YAC-1. E, To quantitate IFN-γ expression, NK cells were stimulated with IL-12/IL-18 in culture (red). Unstimulated NK cells served as controls (gray). IL-15 preactivation was associated with higher IFN-γ expression than was IL-2 or no preactivation. F, Expression analysis of perforin and granzyme B. The expression of perforin was slightly higher in IL-15 than in IL-2-activated NK cells; however, granzyme B was similar.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S3. NK cell ligands in SJNBL46_X passaged in NOD scid Il2rγâ^'/â^' (NSG) and nude mice. A, SJNBL46_X grew in NSG mice and was subsequently analyzed for the expression of NK cell ligands by flow cytometry and reinjected into nude mice. Forming tumors in nude mice underwent the same analysis. Histograms are shown for each ligand (red: NSG mouse, blue: nude mouse, black: isotype). B, The opposite experiment was performed, in which PDX was harvested from nude mice and reinjected into NSG mice. Histograms depict NK cell ligand expression in these tumors (red: nude mouse, blue: NSG mouse, black: isotype). The analysis showed that there were NK cell ligands that did not change expression when tumors from NSG mice were passaged through nude mice (e.g., ULBP2, DR4, CD112, MICA, and MICB) or vice versa (e.g., DR4, DR5, CD112, ULBP3, MICA, and MICB). There were other ligands that were downregulated. However, downregulation was noted in both sub-sets of experiments (e.g., NTB-A and CD155), suggesting that this was not due to host-related immune editing.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
Supplementary Figure S3. NK cell ligands in SJNBL46_X passaged in NOD scid Il2rγâ^'/â^' (NSG) and nude mice. A, SJNBL46_X grew in NSG mice and was subsequently analyzed for the expression of NK cell ligands by flow cytometry and reinjected into nude mice. Forming tumors in nude mice underwent the same analysis. Histograms are shown for each ligand (red: NSG mouse, blue: nude mouse, black: isotype). B, The opposite experiment was performed, in which PDX was harvested from nude mice and reinjected into NSG mice. Histograms depict NK cell ligand expression in these tumors (red: nude mouse, blue: NSG mouse, black: isotype). The analysis showed that there were NK cell ligands that did not change expression when tumors from NSG mice were passaged through nude mice (e.g., ULBP2, DR4, CD112, MICA, and MICB) or vice versa (e.g., DR4, DR5, CD112, ULBP3, MICA, and MICB). There were other ligands that were downregulated. However, downregulation was noted in both sub-sets of experiments (e.g., NTB-A and CD155), suggesting that this was not due to host-related immune editing.